Bio for Elise Everett, M.D., M.S. Elise Everett, M.D., M.S.Associate Professor, Clerkship DirectorDepartment of Obstetrics, Gynecology and Reproductive Sciences Contact Information E-mail: Elise.Everett@uvm.eduPhone: 802-847-5110Office Location: Obstetrics, Gynecology and Reproductive Sciences, FAHC - Smith 405, 111 Colchester Avenue, Burlington, VT 05401 Education2006 Fellowship - Gynecologic Oncology, University of Virginia Medical Center, Charlottesville, VA2004 M.S. - University of Virginia, Charlottesville, VA, Health Evaluation Sciences2003 Residency - Ob/Gyn, University of Washington Medical Center, Seattle, WA1999 M.D. - University of Washington School of Medicine, Seattle, WA 1994 B.A. - Williams College, Williamstown, MA, BiologyExpertiseDr. Everett recently joined the gynecologic oncology faculty here at UVM. Her interests are in medical student and resident education, and simulation training. Dr. Everett is the Director of Simulation for the department and the Medical Student Clerkship Director. Her clinical areas of interest are neoadjuvant chemotherapy for ovarian cancer and the clinical behavior of adenocarcinoma of the cervix. In addition, Dr. Everett has extensive experience in robotic surgery for gynecologic malignancies and is interested in outcome and quality measures related to this new technology.Awards and Honors2013 Association of Professors of Gynecology and Obstetrics Excellence in Teaching Award2012 University of Vermont Medical Student Teaching Award, OB/GYN Clerkship, Rotation 72012 University of Vermont Medical Student Teaching Award, OB/GYN Clerkship, Rotation 62012 University of Vermont Medical Student Teaching Award, OB/GYN Clerkship, Rotation 52012 University of Vermont Faculty Champion in Patient Communication2007, 2010, 2011 University of Washington Teaching Award2004 Mid-Atlantic Gynecologic Oncology Society, best fellow research presentation2003 Leo Legasse Award, Western Association of Gynecologic Oncology, best fellow research presentation2003 David Figge Award, University of Washington, awarded to the chief resident for clinical excellence in Gynecologic OncologyPublicationsPaley PJ, Veljovich DS, Shah CA, Everett EN, Bondurant AE, Drescher CW, Peters WA 3rd. Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 cases. Am J Obstet Gynecol. 2011 Jun;204(6):551.e1-9. doi: 10.1016/j.ajog.2011.01.059. Epub 2011 Mar 16. PubMed PMID: 21411053.Press JZ, Allison KH, Garcia R, Everett EN, Pizer E, Swensen RE, Tamimi HK, Gray HJ, Peters WA 3rd, Goff BA. FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence. Gynecol Oncol. 2011 Feb;120(2):296-9. doi: 10.1016/j.ygyno.2010.10.019. PubMed PMID: 21075432.Veljovich DS, Paley PJ, Drescher CW, Everett EN, Shah C, Peters WA III. Robotic surgery in gynecologic oncology: program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging. Am J Obstet Gynecol (2008)198(6):679.el-9.Bland AE, Everett EN, Pastore LM, Andersen WA, Taylor PT Jr. Predictors of suboptimal surgical cytoreduction in women with advanced epithelial ovarian cancer treated with initial chemotherapy. Int J Gynecol Cancer 2008 Jul-Aug;18(4):629-36. Epub 2007 Nov 6.Everett EN, French AE, Stone RL, Pastore LM, Jazaeri AA, Andersen WA and Taylor PT Jr. Initial chemotherapy followed by surgical cytoreduction for the treatment of stage III/IV epithelial ovarian cancer. Am J Obstet Gynecol (2006)195, 568-76.See PubMed here.